Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06651255
NA

Algorithm-based Management to Reduce the Recurrence of GI Bleeding and Severe Epistaxis in Von Willebrand Disease

Sponsor: University Hospital, Lille

View on ClinicalTrials.gov

Summary

WILL MANAGE is a prospective multicenter controlled open label randomized trial comparing an algorithm-based multidisciplinary management to a standard of care to reduce the incidence of bleeding (GI bleeding or severe epistaxis) recurrence in von Willebrand disease.

Official title: Algorithm-based Management to Reduce the Recurrence of Gastrointestinal Bleeding and Severe Epistaxis in Von Willebrand Disease: WILL-MANAGE Trial

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

66

Start Date

2025-04

Completion Date

2034-12-06

Last Updated

2025-03-13

Healthy Volunteers

No

Interventions

PROCEDURE

Optimized management

systematic gastrointestinal and nasal endoscopic exploration, local endoscopic treatment whenever applicable,prophylaxis with stepwise dose escalation of VWF concentrate and use of antiangiogenic drugs in patients with severe GI angiodysplasia-related bleeding

PROCEDURE

Standard of care management

Standard of care management

Locations (17)

CHU Lille

Lille, Nord, France

CHU Tours

Tours, Tours, France

CHU Amiens

Amiens, France

CHRU Brest

Brest, France

Hôpital cardiologique Louis Pradel

Bron, France

CHU Caen

Caen, France

CH Chambery

Chambéry, France

CHU Clermont-Ferrand

Clermont-Ferrand, France

CHU Dijon

Dijon, France

AP-HP Hôpital Kremlin Bicetre

Le Kremlin-Bicêtre, France

AP-HM Hôpital Timone

Marseille, France

CHU Montpellier

Montpellier, France

CHU Nantes

Nantes, France

CHU Rennes

Rennes, France

CHU Rouen

Rouen, France

CHU Strasbourg

Strasbourg, France

CHU Toulouse

Toulouse, France